» Articles » PMID: 31383668

Production of Norspermidine Contributes to Aminoglycoside Resistance in Mutants of Pseudomonas Aeruginosa

Overview
Specialty Pharmacology
Date 2019 Aug 7
PMID 31383668
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Emergence of resistance to polymyxins in is mainly due to mutations in two-component systems that promote the addition of 4-amino-4-deoxy-l-arabinose to the lipopolysaccharide (LPS) through upregulation of operon () expression. Here, we demonstrate that mutations occurring in different domains of histidine kinase PmrB or in response regulator PmrA result in coresistance to aminoglycosides and colistin. All seventeen clinical strains tested exhibiting such a cross-resistance phenotype were found to be mutants. As shown by gene deletion experiments, the decreased susceptibility of the mutants to aminoglycosides was independent from operon but required the efflux system MexXY-OprM and the products of three genes, PA4773-PA4774-PA4775, that are cotranscribed and activated with genes Gene PA4773 (annotated as in the PAO1 genome) and PA4774 () are predicted to encode enzymes involved in biosynthesis of polyamines. Comparative analysis of cell surface extracts of an selected mutant, called AB16.2, and derivatives lacking PA4773, PA4774, and PA4775 revealed that these genes were needed for norspermidine production via a pathway that likely uses 1,3-diaminopropane, a precursor of polyamines. Altogether, our results suggest that norspermidine decreases the self-promoted uptake pathway of aminoglycosides across the outer membrane and, thereby, potentiates the activity of efflux pump MexXY-OprM.

Citing Articles

An updated overview on the bacterial PhoP/PhoQ two-component signal transduction system.

Mao M, He L, Yan Q Front Cell Infect Microbiol. 2025; 15:1509037.

PMID: 39958932 PMC: 11825808. DOI: 10.3389/fcimb.2025.1509037.


Uncovering a new family of conserved virulence factors that promote the production of host-damaging outer membrane vesicles in gram-negative bacteria.

Goman A, Ize B, Jeannot K, Pin C, Payros D, Goursat C J Extracell Vesicles. 2025; 14(1):e270032.

PMID: 39840902 PMC: 11752146. DOI: 10.1002/jev2.70032.


Mutational signature analysis predicts bacterial hypermutation and multidrug resistance.

Hall K, Williams L, Smith R, Kuang E, Ernst R, Bojanowski C Nat Commun. 2025; 16(1):19.

PMID: 39746975 PMC: 11695600. DOI: 10.1038/s41467-024-55206-w.


Unravelling the mechanisms causing murepavadin resistance in : lipopolysaccharide alterations and its consequences.

Hernandez-Garcia M, Barbero-Herranz R, Baston-Paz N, Diez-Aguilar M, Lopez-Collazo E, Marquez-Garrido F Front Cell Infect Microbiol. 2024; 14:1446626.

PMID: 39711784 PMC: 11659217. DOI: 10.3389/fcimb.2024.1446626.


Antibiotic influx and efflux in Pseudomonas aeruginosa: Regulation and therapeutic implications.

Wu W, Huang J, Xu Z Microb Biotechnol. 2024; 17(5):e14487.

PMID: 38801351 PMC: 11129675. DOI: 10.1111/1751-7915.14487.


References
1.
Nummila K, Kilpelainen I, Zahringer U, Vaara M, Helander I . Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol Microbiol. 1995; 16(2):271-8. DOI: 10.1111/j.1365-2958.1995.tb02299.x. View

2.
Dotsch A, Eckweiler D, Schniederjans M, Zimmermann A, Jensen V, Scharfe M . The Pseudomonas aeruginosa transcriptome in planktonic cultures and static biofilms using RNA sequencing. PLoS One. 2012; 7(2):e31092. PMC: 3272035. DOI: 10.1371/journal.pone.0031092. View

3.
Schurek K, Sampaio J, Kiffer C, Sinto S, Mendes C, Hancock R . Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009; 53(10):4345-51. PMC: 2764176. DOI: 10.1128/AAC.01267-08. View

4.
Ditta G, Stanfield S, Corbin D, Helinski D . Broad host range DNA cloning system for gram-negative bacteria: construction of a gene bank of Rhizobium meliloti. Proc Natl Acad Sci U S A. 1980; 77(12):7347-51. PMC: 350500. DOI: 10.1073/pnas.77.12.7347. View

5.
Sader H, Huband M, Castanheira M, Flamm R . Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States. Antimicrob Agents Chemother. 2017; 61(3). PMC: 5328569. DOI: 10.1128/AAC.02252-16. View